DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹109 Cr | ₹109 Cr | ₹107 Cr | ₹108 Cr | ₹96 Cr |
What is the latest Contingent Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹109 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹108 Cr |
| Mar2021 | ₹96 Cr |
How is Contingent Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹109 Cr | 0.00 | |
| Mar2024 | ₹109 Cr | 1.77 | |
| Mar2023 | ₹107 Cr | -0.37 | |
| Mar2022 | ₹108 Cr | 11.62 | |
| Mar2021 | ₹96 Cr | - | |
Compare Contingent Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹100,218.8 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| MANKIND PHARMA | ₹97,796.9 Cr | -3.1% | -3.3% | -8.6% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -4.1% |
-3.8% |
-4.3% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses